Prevalence of hyperinsulinaemia in patients with high blood pressure. 1992

I Zavaroni, and S Mazza, and E Dall'Aglio, and P Gasparini, and M Passeri, and G M Reaven
Institute of the General Medical Clinic, Parma University, Italy.

A total of 41 patients with hypertension were identified in a survey of 732 healthy factory workers. Twenty-three of these individuals were receiving antihypertensive medication, whereas 18 cases were newly discovered. Plasma glucose and insulin responses to oral glucose and fasting plasma triglyceride (TG), cholesterol, and high-density-lipoprotein (HDL) cholesterol concentrations of these 41 individuals were compared with those of 41 other factor workers, with normal blood pressure, matched with the hypertensive group in terms of gender, age, degree of obesity, job in the factory, and leisure-time activity. Patients with hypertension had significantly higher plasma glucose (P less than 0.05) and insulin (P less than 0.05) concentrations in response to oral glucose, as well as a higher plasma TG concentration (P less than 0.05). Similar findings were obtained when the treated and untreated hypertensive groups were analysed separately and compared with their respective control groups. However, there were no differences between the treated and untreated hypertensive groups. Ninety per cent of the normotensive group had a plasma insulin concentration of less than 500 pmol l-1 2 h after the glucose load. Using this value as the criterion for definition of hyperinsulinaemia, 41% of the patients with high blood pressure were hyperinsulinaemic. In addition to meeting this cut-off point, the patients with hypertension and hyperinsulinaemia were also glucose intolerant and dyslipidaemic. In conclusion, approximately 50% of an unselected group of patients with hypertension were hyperinsulinaemic. Insulin levels were comparable in treated and untreated patients with high blood pressure, and hyperinsulinaemic patients also tended to be glucose intolerant and dyslipidaemic.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous

Related Publications

I Zavaroni, and S Mazza, and E Dall'Aglio, and P Gasparini, and M Passeri, and G M Reaven
May 1992, BMJ (Clinical research ed.),
I Zavaroni, and S Mazza, and E Dall'Aglio, and P Gasparini, and M Passeri, and G M Reaven
January 1989, Clinical and experimental hypertension. Part A, Theory and practice,
I Zavaroni, and S Mazza, and E Dall'Aglio, and P Gasparini, and M Passeri, and G M Reaven
July 1992, Diabetologia,
I Zavaroni, and S Mazza, and E Dall'Aglio, and P Gasparini, and M Passeri, and G M Reaven
October 1980, L' Information dentaire,
I Zavaroni, and S Mazza, and E Dall'Aglio, and P Gasparini, and M Passeri, and G M Reaven
January 2023, Dental and medical problems,
I Zavaroni, and S Mazza, and E Dall'Aglio, and P Gasparini, and M Passeri, and G M Reaven
February 1975, Circulation,
I Zavaroni, and S Mazza, and E Dall'Aglio, and P Gasparini, and M Passeri, and G M Reaven
January 2010, International journal of nursing terminologies and classifications : the official journal of NANDA International,
I Zavaroni, and S Mazza, and E Dall'Aglio, and P Gasparini, and M Passeri, and G M Reaven
December 1997, Clinical science (London, England : 1979),
I Zavaroni, and S Mazza, and E Dall'Aglio, and P Gasparini, and M Passeri, and G M Reaven
January 2021, Medicina,
I Zavaroni, and S Mazza, and E Dall'Aglio, and P Gasparini, and M Passeri, and G M Reaven
June 2016, Annales de cardiologie et d'angeiologie,
Copied contents to your clipboard!